3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Nasopharyngeal Carcinoma
20
Carcinoma, Non-Small-Cell Lung
18
Esophageal Squamous Cell Carcinoma
15
Breast Neoplasms
14
Triple Negative Breast Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
11
Carcinoma, Hepatocellular
11
Stomach Neoplasms
8
Small Cell Lung Carcinoma
8
Uterine Cervical Neoplasms
6
Recurrence
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Transitional Cell
5
Carcinoma, Renal Cell
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Rectal Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Locally Advanced Rectal Cancer
3
Liver Neoplasms
3
Turcot syndrome
2
Pathologic Complete Response
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
Interventions
camrelizumab
3
pembrolizumab
2
apatinib
2
Methylprednisolone
2
Dactinomycin
2
Alemtuzumab
2
zimberelimab
1
toripalimab
1
sargramostim
1
dostarlimab
1
carotuximab
1
aldesleukin
1
Tacrolimus
1
Specimen Handling
1
Prednisone
1
Pemetrexed
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Interleukin-11
1
Interferon-alpha
1
Injections
1
Immunologic Techniques
1
Flow Cytometry
1
Filgrastim
1
CTLA-4 Antigen
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Gestational Trophoblastic Disease
×
toripalimab
×
Clear all
NCT06020755
2024-12-31
TA7
Peking Union Medical College Hospital
Phase 2
Recruiting
17 enrolled